- Figure 10
Impact of Resynchronisation
This case illustrates how important it is to monitor a patient who is being treated for heart failure and also receiving sleep ventilation therapy. As a component of cardiac optimization, CRT may be associated with significant increases in a patient’s LVEF, and several studies have shown that with this change in cardiac function, a patient’s CSA will change. For example, as shown in the study by Kara,[1] if CRT is stopped for just one night, there will be an increase in central apnea; restarting the CRT will decrease the CSA again. Other studies have shown the same results for the AHI, a decrease in AHI following initiation of CRT.[2,3] This effect may have a latency, perhaps as long as >6 months, before ascertaining whether a patient’s sleep apnea improves with the CRT.
References
Kara T, Novak M, Nykodym J, et l. Short-term effects of cardiac resynchronization therapy on sleep-disordered breathing in patients with systolic heart failure. Chest. 2008;134:87–93.
Sinha AM, Skobel EC, Breithardt OA, et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol. 2004;44:68–71.
Gabor JY, Newman DA, Barnard-Roberts V, et al. Improvement in Cheyne-Stokes respiration following cardiac resynchronisation therapy. Eur Respir J. 2005;26:95–100.
